{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:09:51Z","timestamp":1762459791334},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Reactivation viremia is associated with adverse clinical outcomes and immune dysfunction in adults with sepsis. We determined the incidence of viremia and its association with clinical outcomes and immune paralysis phenotype in children with severe sepsis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Prospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Single academic PICU from September 2016 to March 2018.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Fifty-nine patients 2\u201317 years old treated for severe sepsis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>We performed real-time polymerase chain reaction assays on whole blood specimens to determine the incidence of cytomegalovirus. Cytomegalovirus was detected in three patients (5%). All patients with cytomegalovirus viremia were seropositive, with an incidence of 13% in this subset. We additionally performed Epstein-Barr virus and human herpesvirus-6 polymerase chain reaction assays on last available specimens and detected Epstein-Barr virus in 4% and human herpesvirus-6 in 30% of the study population. Overall, viremia was not associated with clinical outcomes or immune function in univariable analyses. However, viremia was associated with lower odds of complicated course (defined as death within 28 d or \u2265 2 organ dysfunctions at 7 d) after controlling for age, Pediatric Risk of Mortality III score, and blood transfusion (adjusted odds ratio, 0.08; 95% CI, 0.01\u20130.84; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.04).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Children with severe sepsis had low rates of detectable viremia, which limited analyses of its association with clinical outcomes or immune paralysis phenotype. Given the rare occurrence of cytomegalovirus viremia, in particular, our study does not support a role for viremia as a biomarker of illness severity or as a modifiable risk factor of clinical outcomes for most patients. Future studies on the role of viremia in pediatric sepsis will need to consider the challenges posed by low rates of viremia in this population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000002185","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T13:23:28Z","timestamp":1573737808000},"page":"e152-e159","source":"Crossref","is-referenced-by-count":3,"title":["Reactivation Viremia in Pediatric Sepsis*"],"prefix":"10.1097","volume":"21","author":[{"given":"Moonjoo","family":"Han","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna L.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Children\u2019s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke A.","family":"Migliore","sequence":"additional","affiliation":[{"name":"Infectious Disease Diagnostics Laboratory, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"C\u00e1rdenas","sequence":"additional","affiliation":[{"name":"Infectious Disease Diagnostics Laboratory, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."},{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Children\u2019s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA."},{"name":"Pediatric Sepsis Program, Children\u2019s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/PCC.0b013e3182917fad","article-title":"Trends in the epidemiology of pediatric severe sepsis.","volume":"14","author":"Hartman","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study.","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure.","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy.","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijid.2014.11.006","article-title":"High circulating CD39(+) regulatory T cells predict poor survival for sepsis patients.","volume":"30","author":"Huang","year":"2015","journal-title":"Int J Infect Dis"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.174.6.3765","article-title":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure.","volume":"174","author":"Felmet","year":"2005","journal-title":"J Immunol"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","article-title":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome.","volume":"37","author":"Hall","year":"2011","journal-title":"Intensive Care Med"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/cc13980","article-title":"Early adaptive immune suppression in children with septic shock: A prospective observational study.","volume":"18","author":"Muszynski","year":"2014","journal-title":"Crit Care"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/cc10069","article-title":"Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.","volume":"15","author":"Heininger","year":"2011","journal-title":"Crit Care"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00003246-200103000-00012","article-title":"Human cytomegalovirus infections in nonimmunosuppressed critically ill patients.","volume":"29","author":"Heininger","year":"2001","journal-title":"Crit Care Med"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.127.1.233","article-title":"Cytomegalovirus infection in critically ill patients: Associated factors and consequences.","volume":"127","author":"Jaber","year":"2005","journal-title":"Chest"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/520307","article-title":"High incidence of active cytomegalovirus infection among septic patients.","volume":"26","author":"Kutza","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients.","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3201\/eid1210.060411","article-title":"Active cytomegalovirus infection in patients with septic shock.","volume":"12","author":"von M\u00fcller","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/2319-4170.132905","article-title":"Epstein-Barr virus reactivation in critically ill immunocompetent patients.","volume":"38","author":"Libert","year":"2015","journal-title":"Biomed J"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/cix120","article-title":"Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock.","volume":"64","author":"Ong","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","article-title":"Reactivation of multiple viruses in patients with sepsis.","volume":"9","author":"Walton","year":"2014","journal-title":"PLoS One"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00430-015-0407-0","article-title":"Sepsis and cytomegalovirus: Foes or conspirators?","volume":"204","author":"Mansfield","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jama.2017.10569","article-title":"Effect of ganciclovir on IL-6 levels among cytomegalovirus-seropositive adults with critical illness: A randomized clinical trial.","volume":"318","author":"Limaye","year":"2017","journal-title":"JAMA"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/PCC.0000000000001376","article-title":"Viral DNAemia and immune suppression in pediatric sepsis.","volume":"19","author":"Davila","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"R21-20230823","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial.","volume":"180","author":"Meisel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/infdis\/jis383","article-title":"Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis.","volume":"206","author":"Unsinger","year":"2012","journal-title":"J Infect Dis"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4049\/jimmunol.0903151","article-title":"IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.","volume":"184","author":"Unsinger","year":"2010","journal-title":"J Immunol"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2011.01.011","article-title":"IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.","volume":"144","author":"Pellegrini","year":"2011","journal-title":"Cell"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.4049\/jimmunol.1202062","article-title":"IL-7 restores lymphocyte functions in septic patients.","volume":"189","author":"Venet","year":"2012","journal-title":"J Immunol"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/cc12711","article-title":"Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis.","volume":"17","author":"Chang","year":"2013","journal-title":"Crit Care"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1073\/pnas.0809422106","article-title":"PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis.","volume":"106","author":"Huang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.0110037","article-title":"Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis.","volume":"88","author":"Brahmamdam","year":"2010","journal-title":"J Leukoc Biol"},{"key":"R29-20230823","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R30-20230823","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/CCM.0b013e31819ffea6","article-title":"Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients.","volume":"37","author":"Chiche","year":"2009","journal-title":"Crit Care Med"},{"key":"R31-20230823","doi-asserted-by":"crossref","first-page":"e51340","DOI":"10.1371\/journal.pone.0051340","article-title":"Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia.","volume":"7","author":"Coisel","year":"2012","journal-title":"PLoS One"},{"key":"R32-20230823","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00000542-199602000-00005","article-title":"Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia.","volume":"84","author":"Papazian","year":"1996","journal-title":"Anesthesiology"},{"key":"R33-20230823","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/JCM.40.7.2381-2386.2002","article-title":"Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.","volume":"40","author":"Sanchez","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R34-20230823","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JCM.38.2.712-715.2000","article-title":"Development of a real-time quantitative assay for detection of Epstein-Barr virus.","volume":"38","author":"Niesters","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R35-20230823","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-0934(01)00390-1","article-title":"Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients.","volume":"100","author":"Gautheret-Dejean","year":"2002","journal-title":"J Virol Methods"},{"key":"R36-20230823","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00134-006-0204-8","article-title":"Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.","volume":"32","author":"Monneret","year":"2006","journal-title":"Intensive Care Med"},{"key":"R37-20230823","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00134-002-1601-2","article-title":"PIM2: A revised version of the Paediatric Index of Mortality.","volume":"29","author":"Slater","year":"2003","journal-title":"Intensive Care Med"},{"key":"R38-20230823","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: An updated Pediatric Risk of Mortality score.","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit Care Med"},{"key":"R39-20230823","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R40-20230823","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","article-title":"Persistent lymphopenia after diagnosis of sepsis predicts mortality.","volume":"42","author":"Drewry","year":"2014","journal-title":"Shock"},{"key":"R41-20230823","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood.V85.5.1341.bloodjournal8551341","article-title":"Downregulation of proinflammatory cytokine release in whole blood from septic patients.","volume":"85","author":"Ertel","year":"1995","journal-title":"Blood"},{"key":"R42-20230823","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","article-title":"Simulation study of confounder-selection strategies.","volume":"138","author":"Maldonado","year":"1993","journal-title":"Am J Epidemiol"},{"key":"R43-20230823","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5935\/0103-507X.20170029","article-title":"Prevalence of multiple organ dysfunction in the pediatric intensive care unit: Pediatric Risk of Mortality III versus Pediatric Logistic Organ Dysfunction scores for mortality prediction.","volume":"29","author":"Hamshary","year":"2017","journal-title":"Rev Bras Ter Intensiva"},{"key":"R44-20230823","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1378\/chest.97.1.18","article-title":"Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery.","volume":"97","author":"Domart","year":"1990","journal-title":"Chest"},{"key":"R45-20230823","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004.","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R46-20230823","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"R47-20230823","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R48-20230823","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nm0509-496","article-title":"The sepsis seesaw: Tilting toward immunosuppression.","volume":"15","author":"Hotchkiss","year":"2009","journal-title":"Nat Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:48:39Z","timestamp":1692838119000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000002185","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}